0001654954-17-001175.txt : 20170217 0001654954-17-001175.hdr.sgml : 20170217 20170217151054 ACCESSION NUMBER: 0001654954-17-001175 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170217 DATE AS OF CHANGE: 20170217 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MABVAX THERAPEUTICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001109196 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930987903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60385 FILM NUMBER: 17621087 BUSINESS ADDRESS: STREET 1: 11535 SORRENTO VALLEY ROAD STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582599405 MAIL ADDRESS: STREET 1: 11535 SORRENTO VALLEY ROAD STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TELIK INC DATE OF NAME CHANGE: 20000313 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Honig Barry C CENTRAL INDEX KEY: 0001373203 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 595 S FEDERAL HIGHWAY STREET 2: SUITE 600 CITY: BOCA RATON STATE: FL ZIP: 33432 FORMER COMPANY: FORMER CONFORMED NAME: Honig Barry R DATE OF NAME CHANGE: 20060818 SC 13G 1 honig13g_feb172017.htm PRIMARY DOCUMENT SEC Connect
 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
SCHEDULE 13G
(Rule 13d-102)
 
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(b)
 
 
MABVAX THERAPEUTICS HOLDINGS, INC.
(Name of Issuer)
 
COMMON STOCK, PAR VALUE $0.01 PER SHARE
 (Title of Class of Securities)
 
55414P 504
(CUSIP Number)
 
December 31, 2016
(Date of Event Which Requires Filing of This Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[   ] Rule 13d-1(b)
[ x] Rule 13d-1(c)
[   ] Rule 13d-1(d)
 
 
 

 
 
 
 
CUSIP No.
55414P 504
 
 
1
 
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Barry Honig
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                      (a) ☐
                                                                                                                                                       (b) ☐
 
3
 
SEC USE ONLY
 
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
 
 
 
NUMBER OF SHARES
 
5
 
SOLE VOTING POWER
 
247,037 (1)
 
BENEFICIALLY
OWNED BY
 
6
 
SHARED VOTING POWER
 
144,611(2)
 
EACH
REPORTING
 
7
 
SOLE DISPOSITIVE POWER
 
247,037 (1)
 
PERSON WITH
 
8
 
SHARED DISPOSITIVE POWER
 
 144,611 (2)
 
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
391,648(1)(2)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
6.22% (Based on 6,296,110 shares outstanding as of November 7, 2016)
 
12
 
TYPE OF REPORTING PERSON
 
IN
 
 
(1)
Represents 247,037 shares of common stock held by Barry Honig. Does not include 374,730 shares of common stock issuable upon conversion of the Company’s Series D Convertible Preferred Stock held by Barry Honig, which contains a 4.99% beneficial ownership blocker.
 
 
(2)
Represents (i) 61,537 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig (“Roth 401K”), for which Barry Honig is trustee and over which securities he holds voting and dispositive power, (ii) 36,000 shares of common stock held by GRQ Consultants, Inc. 401K (“401K”), for which Barry Honig is trustee and over which securities he holds voting and dispositive power and (iii) 47,074 shares of common stock held by Barry & Renee Honig Charitable Foundation (the “Foundation”), for which Barry Honig is trustee and over which securities he holds voting and dispositive power. Does not include (i) 103,950 shares of common stock issuable upon conversion of the Company’s Series F Convertible Preferred Stock held by Roth 401K or (ii) 145,530 shares of common stock issuable upon conversion of the Company’s Series F Convertible Preferred Stock held by GRQ Consultants, Inc. Roth 401K FBO Renee Honig (“Renee 401K”), for which Barry Honig’s spouse, Renee Honig, is trustee and over which securities she holds voting and dispositive power. The Series F Convertible Preferred Stock contains a 4.99% beneficial ownership blocker. Additionally, does not include (i) 207,900 shares of common stock underlying warrants held by Roth 401K, (ii) 70,166 shares of common stock underlying warrants held by 401K, (iii) 415,800 shares of common stock underlying warrants held by Renee 401K or (iv) 62,370 shares of common stock underlying warrants held by the Foundation. All of these warrants contain a 4.99% beneficial ownership blocker.
 
 
 
 
 
 
CUSIP No.
55414P 504
 
 
1
 
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
GRQ Consultants, Inc. Roth 401K FBO Barry Honig
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                           (a) ☐
                                                                                                                                            (b) ☐
 
3
 
SEC USE ONLY
 
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
 
 
 
NUMBER OF SHARES
 
5
 
SOLE VOTING POWER
 
0
 
BENEFICIALLY
OWNED BY
 
6
 
SHARED VOTING POWER
 
61,537(1)
 
EACH
REPORTING
 
7
 
SOLE DISPOSITIVE POWER
 
0
 
PERSON WITH
 
8
 
SHARED DISPOSITIVE POWER
 
61,537 (1)
 
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
61,537 (1)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
.98% (Based on 6,296,110 shares outstanding as of November 7, 2016)
 
12
 
TYPE OF REPORTING PERSON*
 
OO
 
 
(1)
Barry Honig is the trustee of Roth 401K and in such capacity holds voting and dispositive power over the securities held by Roth 401K. Does not include (i) 103,950 shares of common stock issuable upon conversion of the Company’s Series F Convertible Preferred Stock and (ii) 207,900 shares of common stock underlying warrants held by Roth 401K, which each contain a 4.99% beneficial ownership blocker.
 
 
 
 
 
 
CUSIP No.
55414P 504
 
 
1
 
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
GRQ Consultants, Inc. 401K
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                  (a) ☐
                                                                                                                                                   (b) ☐
 
3
 
SEC USE ONLY
 
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
 
 
 
NUMBER OF SHARES
 
5
 
SOLE VOTING POWER
 
0
 
BENEFICIALLY
OWNED BY
 
6
 
SHARED VOTING POWER
 
36,000(1)
 
EACH
REPORTING
 
7
 
SOLE DISPOSITIVE POWER
 
0
 
PERSON WITH
 
8
 
SHARED DISPOSITIVE POWER
 
36,000 (1)
 
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 36,000 (1)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
.57% (Based on 6,296,110 shares outstanding as of November 7, 2016)
 
12
 
TYPE OF REPORTING PERSON*
 
OO
 
 
(1)
Barry Honig is the trustee of 401K and in such capacity holds voting and dispositive power over the securities held by 401K. Does not include 70,166 shares of common stock underlying warrants held by 401K, which contain a 4.99% beneficial ownership blocker.
 
 
 
 
 
CUSIP No.
55414P 504
 
 
1
 
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Barry & Renee Honig Charitable Foundation Inc.
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                  (a) ☐
                                                                                                                                                  (b) ☐
 
3
 
SEC USE ONLY
 
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
 
 
 
NUMBER OF SHARES
 
5
 
SOLE VOTING POWER
 
0
 
BENEFICIALLY
OWNED BY
 
6
 
SHARED VOTING POWER
 
47,074(1)
 
EACH
REPORTING
 
7
 
SOLE DISPOSITIVE POWER
 
0
 
PERSON WITH
 
8
 
SHARED DISPOSITIVE POWER
 
47,074(1)
 
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 47,074 (1)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
.75% (Based on 6,296,110 shares outstanding as of November 7, 2016)
 
12
 
TYPE OF REPORTING PERSON*
 
OO
 
 
(1)
Barry Honig is the trustee of the Foundation and in such capacity holds voting and dispositive power over the securities held by the Foundation. Does not include 62,370 shares of common stock underlying warrants held by the Foundation, which contain a 4.99% beneficial ownership blocker.
 
 
 
 
 
 
Item 1(a).
Name of Issuer:
                     
MabVax Therapeutics Holdings, Inc. (“Issuer”)
 
Item 1(b).
Address of Issuer's Principal Executive Offices:
 
11535 Sorrento Valley Road, Suite 400, San Diego, California 92121
 
Item 2(a).
Name of Person Filing.
 
The statement is filed on behalf of Barry Honig, GRQ Consultants, Inc. Roth 401K FBO Barry Honig, GRQ Consultants, Inc. 401K and Barry & Renee Honig Charitable Foundation Inc. (collectively, the “Reporting Persons”).
 
Item 2(b).
Address of Principal Business Office or, if None, Residence.
 
555 South Federal Highway #450, Boca Raton, FL 33432
 
Item 2(c).
Citizenship.
 
Barry Honig is a citizen of the United States. Roth 401K, 401K and the Foundation are organized in the State of Florida.
 
Item 2(d).
Title of Class of Securities.
             
Common Stock, par value $0.01.
 
Item 2(e).
CUSIP Number.
         
55414P 504
 
Item 3.
Type of Person
 
Not applicable.
 
Item 4.
Ownership.
    
(a) Amount beneficially owned:  391,648(1)(2)
 
(b) Percent of class:  6.22% (Based on 6,296,110 shares outstanding as of November 7, 2016)
 
(c) Number of shares as to which the person has:
 
(i) Sole power to vote or to direct the vote: 247,037 (1)
(ii) Shared power to vote or to direct the vote:  144,611(2)
(iii) Sole power to dispose or to direct the disposition of: 247,037 (1)
(iv) Shared power to dispose or to direct the disposition of:  144,611(2)
 
 
(1)
Represents 247,037 shares of common stock held by Barry Honig. Does not include 374,730 shares of common stock issuable upon conversion of the Company’s Series D Convertible Preferred Stock held by Barry Honig, which contains a 4.99% beneficial ownership blocker.
 
 
(2)
Represents (i) 61,537 shares of common stock held by Roth 401K, (ii) 36,000 shares of common stock held by 401K and (iii) 47,074 shares of common stock held by the Foundation. Does not include (i) 103,950 shares of common stock issuable upon conversion of the Company’s Series F Convertible Preferred Stock held by Roth 401K or (ii) 145,530 shares of common stock issuable upon conversion of the Company’s Series F Convertible Preferred Stock held by Renee 401K. The Series F Convertible Preferred Stock contains a 4.99% beneficial ownership blocker. Additionally, does not include (i) 207,900 shares of common stock underlying warrants held by Roth 401K, (ii) 70,166 shares of common stock underlying warrants held by 401K, (iii) 415,800 shares of common stock underlying warrants held by Renee 401K or (iv) 62,370 shares of common stock underlying warrants held by the Foundation. All of these warrants contain a 4.99% beneficial ownership blocker.
 
 
 
 
 
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
Not applicable.
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
Not applicable.
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.
                
Not applicable.
 
Item 8.
Identification and Classification of Members of the Group.
             
Not applicable.
 
Item 9.
Notice of Dissolution of Group.
             
Not applicable.
 
Item 10.
Certifications.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
 
 
Date: February 17, 2017
By:  
/s/ Barry Honig
 
 
Barry Honig
 
 
 
 
 
 
 
 
GRQ Consultants, Inc. Roth 401K FBO Barry Honig
 
Date: February 17, 2017
 
By:  
 
/s/ Barry Honig
 
 
Barry Honig, Trustee
 
 
 
 
GRQ Consultants, Inc. 401K
 
Date: February 17, 2017
 
By:  
 
/s/ Barry Honig
 
 
Barry Honig, Trustee
 
 
Barry & Renee Honig Charitable Foundation Inc.
 
Date: February 17, 2017
 
By:  
 
/s/ Barry Honig
 
 
Barry Honig, Trustee